Regeneron Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | Outperform |
9
|
$160.81 | $178.42 | 15.04% | 11 | $284.74B |
| VZ | Verizon Communications | Outperform |
6
|
$38.93 | $45.10 | 18.16% | 9 | $163.87B |
| PFE | Pfizer | Outperform |
2
|
$27.70 | $32.87 | 10.11% | 6 | $156.85B |
| CMCSA | Comcast Corp | Outperform |
10
|
$38.36 | $50.29 | 25.13% | 7 | $150.51B |
| AMGN | Amgen | Outperform |
4
|
$278.39 | $303.65 | 14.77% | 8 | $149.32B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.70 | $58.15 | 23.57% | 10 | $88.58B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.33 | $87.82 | 22.46% | 14 | $81.46B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.09k | ¥4.92k | 20.73% | 0 | ¥8.38T |
| 2914 | Japan Tobacco | Hold |
6
|
¥4.30k | ¥3.25k | -4.72% | 0 | ¥7.64T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| ALC | Alcon | Outperform |
8
|
CHF71.20 | CHF90.64 | 35.34% | 3 | CHF35.12B |
| BIIB | Biogen | Outperform |
10
|
$213.51 | $299.62 | 35.12% | 13 | $31.09B |
| CE | Celanese | Hold |
13
|
$156.38 | $148.23 | 2.31% | 18 | $17.45B |
| BGNE | BeiGene | Buy |
6
|
$162.01 | $285.19 | 69.74% | 2 | $16.94B |
| INCY | Incyte | Outperform |
9
|
$53.09 | $77.05 | 47.86% | 8 | $11.89B |
| UTHR | United Therapeutics | Outperform |
12
|
$258.13 | $284.08 | 16.22% | 3 | $11.32B |
| EXEL | Exelixis | Outperform |
16
|
$22.12 | $26.44 | 22.06% | 5 | $6.44B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$109.29 | $188.32 | 72.02% | 4 | $6.88B |
| SPIE | SPIE | Outperform |
18
|
34.44€ | 32.33€ | 13.24% | 6 | 5.69€B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$43.09 | $55.60 | 39.24% | 3 | $6.02B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.09 | $9.50 | 17.43% | 5 | $3.21B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥21.70 | ¥24.00 | -100.00% | 1 | ¥19.95B |
| MRUS | Merus N.V. | Buy |
6
|
$47.50 | $43.70 | 22.11% | 7 | $2.64B |
| 500674 | Sanofi India | Outperform |
18
|
Rp8.68k | Rp8.61k | 5.65% | 0 | Rp191.71B |
| GLPG | Galapagos NV | Hold |
6
|
27.34€ | 39.85€ | 32.59% | 2 | 1.80€B |
| LGND | Ligand Pharmaceuticals | Outperform |
14
|
$72.32 | $111.83 | 52.10% | 3 | $1.26B |
| FYB | Formycon | Buy |
11
|
41.00€ | 106.60€ | 119.51% | 0 | 723.18€M |
| 4551 | Torii Pharmaceutical | Outperform |
14
|
¥3.96k | ¥4.04k | 9.85% | 0 | ¥110.75B |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.17 | $10.86 | 268.66% | 3 | $222.46M |
| ALIM | Alimera Sciences | Buy |
9
|
$3.48 | $7.00 | 129.89% | 3 | $185.33M |
| OPTN | OptiNose | Buy |
6
|
$0.88 | $3.00 | 297.73% | 2 | $100.73M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.18 | $0.65 | 455.56% | 0 | $56.27M |
| XBRANE | Xbrane Biopharma AB (publ) | Outperform |
5
|
kr0.21 | kr116.00 | 200.00% | 0 | kr538.38M |
| IRIX | IRIDEX | Hold |
9
|
$2.85 | $2.00 | -29.82% | 0 | $42.41M |
| ACST | Acasti Pharma | Buy |
0
|
$3.03 | $16.34 | 166.01% | 0 | $26.98M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |